NCT05658107View on ClinicalTrials.gov

A Study to Test How Different Doses of BI 765423 Are Taken up in the Body of Healthy Men

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

January 16, 2023

Primary Completion Date

March 19, 2024

Study Completion Date

March 19, 2024

Conditions
Healthy
Interventions
DRUG

BI 765423

BI 765423

DRUG

Placebo

Placebo

Trial Locations (1)

2650

SGS Life Science Services - Clinical Research, Edegem

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY